Mercer Global Advisors
BNGO icon

Mercer Global Advisors’s Bionano Genomics BNGO Stock Holding History

Mercer Global Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Buy
+1
New +$1 ﹤0.01% 6099

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CWP
Concord Wealth Partners Abingdon, Virginia $873M AUM 24.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mercer Global Advisors's BNGO Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Bionano Genomics (BNGO) in Q2 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #6099 among its holdings.

13 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • Mercer Global Advisors held 1 share of Bionano Genomics worth $1 as of Q2 2026.
  • Bionano Genomics was a new Mercer Global Advisors position in Q2 2026.
  • Bionano Genomics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #6099 holding.
  • 13 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.